ERBB2 and breast cancer: Two recent studies have demonstrated that basal-like and human epidermal growth factor receptor 2 positive (HER2+) breast cancer (BC) cells exhibit elevated de novo lipogenesis (DNL) rates when proliferating in brain metastatic sites compared to their primary tumors.